Cancer Institute A national cancer institute
designated cancer center

Search all open clinical trials at Stanford

Are you thinking of entering a clinical trial? Learn more here.

Español | 中文 | Pусский

View stories from Cancer Clinical Trial participants at Stanford.

Cost of Clinical Trials

If you are considering a clinical trial, the potential cost of being in a trial may factor into your decision to participate. Read more about the different costs for clinical trials here.

Phase 1 Safety Study of X-396, an Oral ALK Inhibitor, in Patients With Advanced Solid Tumors

This is the first human study to use X-396, a drug being developed for treatment of advanced cancers. The main purpose of the study is to determine the largest amount of X-396 that can be safely given to humans (the maximum tolerated dose). The study will also provide early information on how the body handles the drug (pharmacokinetics) and on the efficacy of X-396.

Stanford Medicine Resources:

Footer Links: